WINNIPEG – Medical technology firm IMRIS Inc. (TSX:IM) reported a loss in its most recent quarter, when revenue fell sharply as hospitals delayed the installation of its surgical theatre systems.
The company, which keeps its books in U.S. dollars, said Monday it lost US$8.5 million or 19 cents per share for the quarter ended Sept. 30 compared with a profit of $744,000 or two cents per share a year ago.
Sales fell to $7.2 million, down from $16.8 million.
Get weekly money news
“The current macroeconomic environment and associated uncertainty is having an impact on capital spending by hospitals and we are seeing that translate into longer sales cycles and longer installation times,” chief executive David Graves said in a statement.
The company noted that the delayed installations totalled about $10 million in revenue, which is now expected to be earned in later quarters.
- Alberta tweaks carbon capture incentive program to allow grants during construction
- ‘Cash is king’: Why money is a popular holiday present for many Canadians
- Rancher says Alberta well cleanup fund a positive step — but litany of concerns remain
- What makes the Anthropic IPO so significant, and what is the ‘god share’?
Service contracts totalled $900,000 for the quarter, up from $400,000 a year ago.
In its outlook, the company said it expects annual revenues for 2011 to be in the range of $50 million to $53 million based on its installation schedule.
Sales for the nine months ended Sept. 30 totalled $37.1 million, down from $45.4 million for the first nine months of 2010.
Shares in the company closed down eight cents at $3.31 on the Toronto Stock Exchange on Monday.
Comments
Want to discuss? Please read our Commenting Policy first.